115.61

0.34% -0.3158

Abbott Laboratories (ABT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$115.93

Offen:

$115.68

24-Stunden-Volumen:

1.05M

Relative Volume:

0.24

Marktkapitalisierung:

$201.34B

Einnahmen:

$41.22B

Nettoeinkommen (Verlust:

$5.77B

KGV:

39.32

EPS:

2.94

Netto-Cashflow:

$6.49B

1W Leistung:

+0.44%

1M Leistung:

-1.24%

6M Leistung:

+12.22%

1J Leistung:

+13.37%

1-Tages-Spanne:

$115.14

$116.12

1-Wochen-Bereich:

$114.43

$117.94

52-Wochen-Spanne:

$99.71

$121.64

Abbott Laboratories Stock (ABT) Company Profile

Firmenname

Abbott Laboratories

Sektor

Healthcare (1195)

Branche

Medical Devices (152)

Telefon

(224) 667-6100

Adresse

100 ABBOTT PARK ROAD, ABBOTT PARK, IL

Mitarbeiter

114,000

Twitter

@AbbottNews

Nächster Verdiensttermin

2024-10-16

Neueste SEC-Einreichungen

ABT's Discussions on Twitter

Vergleichen Sie ABT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ABT	115.55	201.34B	41.22B	5.77B	6.49B	2.94
SYK	387.10	146.32B	21.97B	3.59B	3.21B	6.74
BSX	90.94	132.22B	15.91B	1.79B	1.89B	0.82
MDT	84.44	107.39B	33.00B	4.29B	5.50B	2.71
EW	69.89	41.01B	6.60B	4.16B	490.10M	2.34

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-10-08	Eingeleitet	Oppenheimer	Outperform
2024-09-19	Eingeleitet	Piper Sandler	Overweight
2024-07-30	Herabstufung	Edward Jones	Buy → Hold
2024-05-30	Eingeleitet	Goldman	Buy
2023-07-21	Hochstufung	Wolfe Research	Underperform → Peer Perform
2023-05-30	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2023-04-20	Bestätigt	Barclays	Overweight
2023-04-20	Bestätigt	Bernstein	Outperform
2023-04-20	Bestätigt	JP Morgan	Overweight
2023-04-20	Bestätigt	Raymond James	Outperform
2023-04-20	Bestätigt	UBS	Buy
2023-04-20	Bestätigt	Wolfe Research	Underperform
2023-03-29	Eingeleitet	UBS	Buy
2022-10-26	Eingeleitet	Mizuho	Neutral
2022-10-18	Eingeleitet	Barclays	Overweight
2022-10-12	Eingeleitet	Jefferies	Hold
2022-07-06	Eingeleitet	Wolfe Research	Underperform
2022-03-02	Fortgesetzt	BofA Securities	Buy
2022-01-27	Bestätigt	Credit Suisse	Outperform
2022-01-27	Bestätigt	Morgan Stanley	Overweight
2022-01-27	Bestätigt	Raymond James	Outperform
2022-01-27	Bestätigt	UBS	Buy
2021-12-10	Eingeleitet	RBC Capital Mkts	Outperform
2021-10-27	Hochstufung	Atlantic Equities	Neutral → Overweight
2021-10-14	Eingeleitet	Redburn	Neutral
2021-05-25	Eingeleitet	Barclays	Overweight
2021-04-15	Eingeleitet	Atlantic Equities	Neutral
2021-01-28	Hochstufung	BTIG Research	Neutral → Buy
2020-09-11	Eingeleitet	Wolfe Research	Outperform
2020-06-01	Herabstufung	Goldman	Neutral → Sell
2020-03-05	Eingeleitet	Citigroup	Buy
2020-02-13	Eingeleitet	Goldman	Neutral
2020-02-06	Fortgesetzt	BTIG Research	Neutral
2020-01-02	Herabstufung	Guggenheim	Buy → Neutral
2019-06-13	Bestätigt	BofA/Merrill	Buy
2019-02-07	Bestätigt	BofA/Merrill	Buy
2019-01-02	Herabstufung	Citigroup	Neutral → Sell
2018-11-30	Hochstufung	Goldman	Neutral → Buy
2018-10-16	Eingeleitet	Barclays	Overweight
2018-06-27	Eingeleitet	Bernstein	Outperform
2018-01-30	Bestätigt	Citigroup	Neutral
2018-01-25	Bestätigt	Stifel	Buy
2018-01-25	Hochstufung	William Blair	Mkt Perform → Outperform
2018-01-03	Eingeleitet	Evercore ISI	Outperform
2018-01-02	Hochstufung	JP Morgan	Neutral → Overweight
2018-01-02	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2017-10-19	Bestätigt	RBC Capital Mkts	Outperform
2017-10-19	Bestätigt	Stifel	Buy

Alle ansehen

Abbott Laboratories Aktie (ABT) Neueste Nachrichten

08:11 AM

German American Bancorp Inc. Raises Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat

08:11 AM

06:51 AM

King Luther Capital Management Corp Lowers Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat

06:51 AM

Nov 20, 2024

Abbott Laboratories stock underperforms Wednesday when compared to competitors - MarketWatch

Nov 20, 2024

Is Trending Stock Abbott Laboratories (ABT) a Buy Now? - Yahoo Finance

Nov 20, 2024

Portfolio Design Labs LLC Has $2.12 Million Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat

Nov 20, 2024

Plant-based Beverage Market is Estimated to Reach $56.73 Billion with a 11.9% CAGR By 2034 | Fact.MR Reports - GlobeNewswire Inc.

Nov 20, 2024

Abbott Laboratories (NYSE:ABT) Shares Acquired by Avior Wealth Management LLC - MarketBeat

Nov 20, 2024

Nov 19, 2024

No magic with Abbott’s Amulet compared to Watchman - BioWorld Online

Nov 19, 2024

Abbott Laboratories stock outperforms competitors despite losses on the day - MarketWatch

Nov 19, 2024

Abbott opens CGM sensor manufacturing facility in Ireland as part of $465M investment - Cardiovascular Business

Nov 19, 2024

Abbott opens plant in Ireland to boost Libre 3 sensor production - MedTech Dive

Nov 19, 2024

Abbott reports positive Amplatzer Amulet data in head-to-head trial with Boston Scientific's Watchman - Mass Device

Nov 19, 2024

West Family Investments Inc. Takes $544,000 Position in Abbott Laboratories (NYSE:ABT) - MarketBeat

Nov 19, 2024

PNC Financial Services Group Inc. Sells 25,295 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat

Nov 19, 2024

Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy? - Yahoo Finance

Nov 19, 2024

Banque Cantonale Vaudoise Boosts Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat

Nov 19, 2024

Abbott Laboratories (NYSE:ABT) Holdings Decreased by Wrapmanager Inc. - MarketBeat

Nov 19, 2024

Fifth Third Wealth Advisors LLC Buys 4,705 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat

Nov 19, 2024

Prospera Financial Services Inc Raises Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat

Nov 19, 2024

Abbott opens new manufacturing facility for diabetes business in Ireland - Yahoo News

Nov 19, 2024

Abbott Laboratories (NYSE:ABT) Shares Bought by Pathstone Holdings LLC - MarketBeat

Nov 19, 2024

Thrivent Financial for Lutherans Has $52.22 Million Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat

Nov 19, 2024

Nov 18, 2024

Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch

Nov 18, 2024

Abbott opens new Kilkenny site for diabetes tech - SiliconRepublic.com

Nov 18, 2024

Mawer Investment Management Ltd. Sells 24,407 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat

Nov 18, 2024

Abbott Opens New Diabetes Care Mfg Facility in Ireland - MPO-mag

Nov 18, 2024

First Western Trust Bank Lowers Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat

Nov 18, 2024

Abbott opens new FreeStyle Libre manufacturing plant in Ireland - Mass Device

Nov 18, 2024

MAI Capital Management Sells 9,904 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat

Nov 18, 2024

US medtech firm Abbott creates 800 jobs in Kilkenny - Irish Independent

Nov 18, 2024

Abbott Opens State-of-the-Art Global Manufacturing Facility in Kilkenny, Ireland - cnhinews.com

Nov 18, 2024

Nov 17, 2024

Swiss National Bank Purchases 26,000 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat

Nov 17, 2024

With 77% institutional ownership, Abbott Laboratories (NYSE:ABT) is a favorite amongst the big guns - Simply Wall St

Nov 17, 2024

Mizuho Securities USA LLC Has $12.86 Million Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat

Nov 17, 2024

Mutual of America Capital Management LLC Has $24.39 Million Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat

Nov 17, 2024

Abbott Laboratories (NYSE:ABT) Shares Sold by Mizuho Markets Americas LLC - MarketBeat

Nov 17, 2024

Nov 16, 2024